Literature DB >> 18816687

Does smoking decrease the response to infliximab in patients with Crohn's disease?

Mansour A Parsi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18816687     DOI： 10.1002/ibd.20675

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  2 in total

1.  Genetic polymorphisms in metabolizing enzymes modifying the association between smoking and inflammatory bowel diseases.

Authors:  Ashwin N Ananthakrishnan; Deanna D Nguyen; Jenny Sauk; Vijay Yajnik; Ramnik J Xavier
Journal:  Inflamm Bowel Dis       Date:  2014-05       Impact factor: 5.325

2.  Early diagnosis and treatment of postoperative endoscopic recurrence of Crohn's disease: partial benefit by infliximab--a pilot study.

Authors:  Dario Sorrentino; Giovanni Terrosu; Alberto Paviotti; Marco Geraci; Claudio Avellini; Giorgio Zoli; Walter Fries; Silvio Danese; Pietro Occhipinti; Tiziano Croatto; Dimitra Zarifi
Journal:  Dig Dis Sci       Date:  2012-01-18       Impact factor: 3.199
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.